To date there is no treatment for<unk>  albinism, probably because little is known about the receptor function and its role in the pathophysiology of the condition. Though surgery for strabismus is sometimes helpful, there does not seem to be a sure remedy for it until the cause of<unk>  albinism is well established. However, with the recent discovery of the upstream ligand (L-DOPA) and the discovery of<unk> 's possible downstream G alpha partner (Gai3) the<unk>  pathway is becoming clearer and future of<unk>  research looks promising. Touloukian et al. have characterized<unk>  immunologically as a melanoma/melanocyte differentiation antigen. Flow cytometry data suggests that<unk> -specific T cells are all CD8+. This indicates that<unk>  peptide is processed and presented on the surface of melanoma cells to be recognized by antigen-specific T cells. Moreover, recognition of<unk>  by T cells induces cytokine production by the<unk> -specific T cells. This means that<unk>  is a potential target for melanoma vaccines.
Ocular albinism type 1
Oculocutaneous albinism type I
Oculocutaneous albinism
Retinoschisis
Lafora disease
Leber congenital amaurosis
Bayoud disease
Tangier disease